United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 5.20%58.116.5%$171.84m
CTLTCatalent, Inc. 1.14%73.572.1%$126.59m
JAZZJazz Pharmaceuticals Plc 1.32%111.202.4%$115.14m
VRXValeant Pharmaceuticals International, Inc. 3.52%18.9914.1%$111.74m
BHCBausch Health Cos., Inc. 3.52%18.990.0%$80.52m
UTHRUnited Therapeutics Corp. -1.07%119.0414.3%$72.13m
ICPTIntercept Pharmaceuticals, Inc. -2.10%46.1016.8%$63.85m
AXSMAxsome Therapeutics, Inc. 1.28%82.011.9%$53.15m
ZGNXZogenix, Inc. -0.41%29.077.5%$52.48m
PRGOPerrigo Co. Plc 0.22%55.316.8%$49.65m
MYOKMyoKardia, Inc. -1.99%92.241.8%$46.56m
AMRNAmarin Corp. Plc 0.87%6.981.6%$42.77m
PCRXPacira Biosciences, Inc. 3.61%54.2610.3%$41.59m
ARGXargenx SE 3.07%235.740.0%$40.62m
GWPHGW Pharmaceuticals Plc 0.94%126.536.2%$39.01m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.